Chromosome Microarray (CMA) Detection (3) - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

Assess chromosomal abnormalities and investigate the genetic causes of recurrent miscarriage and infertility.

PREV: Chromosome Microarray (CMA) Detection 2.0 (4)

NEXT: Chromosome Microarray (CMA) Detection

Related IVD Products

Related News Of IVD Technology

Unveiling the Microbial World: The Power of Whole Genome Shotgun MetagenomicsJune 5, 2024Whole genome shotgun metagenomics is a revolutionary technique that allows scientists to sequence the genomes of entire microbial communities without the need for culturing them first. This groundbrea...view
Unveiling the Immune Fingerprint: Exploring HLA Typing with CapitalBioFebruary 8, 2024Human leukocyte antigen (HLA) typing, also known as HLA genotyping, unlocks a wealth of information about an individual's immune system. These unique molecules, expressed on the surface of cells, ...view
Innovative Application of Microfluidic Platform in Agricultural Product TestingMay 22, 2024With rapid development of modern agriculture, the importance of agricultural product testing is becoming more and more prominent. In order to ensure consumer food safety and meet market demand, the ef...view
Beyond the Pixels: Exploring the Power of Microarray Scanners in Genetic AnalysisJanuary 4, 2024Genetic analysis has revolutionized the field of biology and medical research by providing invaluable insights into the functioning of genes and their impact on various biological processes. The emerg...view
What Are the Main Processes of DNA Microarray Technology?March 8, 2023The principle of DNA microarray technology is to integrate gene probes with known sequences onto a solid surface. A large number of labeled nucleic acid sequences from the tested biological cells or t...view
CapitalBio: Revolutionizing Genomics with Advanced Microarray ScannersFebruary 7, 2024Introduction to CapitalBio and Microarray TechnologyCapitalBio, a global leader in biotechnology, is revolutionizing the field of genomics with its advanced microarray scanners. These instruments, inc...view